Research
Hormonal
GLP-1 receptor agonists delay gastric emptying, which reduces postprandial lipid and carbohydrate surges and contributes to satiety.
GLP-1 medications slow down how fast food leaves your stomach. This helps you feel full longer and prevents sharp spikes in blood sugar after meals.
StrongSupportsHIGH confidence
GLP-1 delays the gastric emptying, thereby reducing the postprandial lipid and carbohydrate surges. This effect of GLP-1 is at least partially mediated by the neuronal pathway, including afferent vagal nerve, brainstem (e.g., NST), and efferent vagal nerve.
Why this rating
Supported by physiological descriptions and figure legends.
Source
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Qiyuan Keith Liu · Frontiers in Endocrinology · 2024
DOI 10.3389/fendo.2024.1431292
narrative_reviewCited 171×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Dual GIP/GLP-1 receptor agonists (e.g., tirzepatide) and GLP-1 receptor agonists (e.g., semaglutide) induce significant weight loss and improve glycemic control in patients with type 2 diabetes and obesity by acting on central satiety centers and peripheral metabolic pathways.Strong
- GIP promotes lipogenesis (fat storage) in adipose tissue, while GLP-1 promotes lipolysis (fat breakdown) indirectly via sympathetic nervous system activation.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →